Evidence map›Paper›PMID 37970598›Full record

ArticleAnnals of translational medicine2023

Mortality reduction in severe community-acquired pneumonia: key findings from a large randomized controlled trial and their clinical implications.

Ovidiu Vornicu, Emily Perriens, Sydney Blackman, Elina Smoos, Christophe Al Sammour, Ilann Oueslati, Alexis Philippot, David Vidal Bankier, Charbel Haddad, Maha Bendoumou and 6 more

Abstract readEditorialComment
PubMed Full text at PMC Publisher
In one paragraph

Article in Annals of translational medicine, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Observational
  2. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

16 authors.

Ovidiu VornicuICU, CHU UCL Godinne Namur, UCL Louvain Medical School, Yvoir, Belgium.
Emily PerriensULB University Centre Hospitalier Universitaire Brugmann, Brussels, Belgium.
Sydney BlackmanULB University Centre Hospitalier Universitaire Brugmann, Brussels, Belgium.
Elina SmoosULB University, Brussels, Belgium.
Christophe Al SammourULB University, Brussels, Belgium.
Ilann OueslatiULB University, Brussels, Belgium.
Alexis PhilippotULB University, Brussels, Belgium.
David Vidal BankierULB University, Brussels, Belgium.
Charbel HaddadULB University, Brussels, Belgium.
Maha BendoumouULB University, Brussels, Belgium.
Tom FrançoisULB University, Brussels, Belgium.
Isabelle MichauxICU, CHU UCL Godinne Namur, UCL Louvain Medical School, Yvoir, Belgium.
Anne-Sophie DincqICU, CHU UCL Godinne Namur, UCL Louvain Medical School, Yvoir, Belgium.
Patrick EvrardICU, CHU UCL Godinne Namur, UCL Louvain Medical School, Yvoir, Belgium.
Pierre BulpaICU, CHU UCL Godinne Namur, UCL Louvain Medical School, Yvoir, Belgium.
Patrick M HonoreICU, CHU UCL Godinne Namur, UCL Louvain Medical School, Yvoir, Belgium.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

28 days mortalityhydrocortisoneimplications for cliniciansseptic shock excludedSevere community-acquired pneumonia (severe CAP)

Identifiers

PMID37970598
PMCPMC10632581

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.